Myriad Posts Strong FY2013 Revenue Growth as It Preps New Dx Launches, Aims to Hold Off Competition | GenomeWeb

In the last fiscal quarter of 2013 Myriad Genetics' business faced some challenges, although one wouldn't know it by looking at the company's earnings.

In May, actress Angelina Jolie wrote in a New York Times editorial about her decision to get a preventive double mastectomy after learning she harbored BRCA mutations. In the same piece, she mentioned that the cost of BRCA testing is more than $3,000 in the US and "remains an obstacle for many women."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.